Click here to view online. Add this email to your safelist.
AstraZeneca to invest $360m in advanced manufacturing facility in Ireland
21 September 2021
AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin, Ireland to ensure the Company’s global supply network is fit for future growth.
|
|||||
|
|||||
|
For more information please visit astrazeneca.com. If you would like to unsubscribe please click here. |
